Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Smith David Ross, Chief Financial Officer. Director active across 3 companies, notably Charles River Laboratories International, INC.. Cumulatively, 10 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €208k. History available since 4 May 2021. The latest transaction was filed on 20 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Smith David Ross is Chief Financial Officer and Executive Vice President at Charles River Laboratories International, Inc. He oversees the financial operations of the company, ensuring financial health and compliance.